Farmers & Merchants Investments Inc Uni Qure N.V. Transaction History

Farmers & Merchants Investments Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	BUY	$16.98 - $25.54 $543 - $817	32 New	32 $1,000
Q1 2022 Apr 19, 2022	SELL	$14.54 - $21.5 $1,802 - $2,666	-124 Closed	0 $0
Q4 2021 Jan 14, 2022	SELL	$20.24 - $36.01 $1,396 - $2,484	-69 Reduced 35.75%	124 $3,000
Q2 2021 Jul 16, 2021	BUY	$29.97 - $37.17 $2,217 - $2,750	74 Added 62.18%	193 $6,000
Q3 2020 Oct 19, 2020	BUY	$35.98 - $47.66 $4,281 - $5,671	119 New	119 $4,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Farmers & Merchants Investments Inc, based on Form 13F filings with the SEC.

Stay updated on Farmers & Merchants Investments Inc with notifications on news.